Applicability of the lung-molGPA index in non-small cell lung cancer patients with different gene alterations and brain metastases

In the era of precision medicine, Lung-molGPA accurately predicted the prognosis of NSCLC patients with mutant genotypes and BM, although it did not perform well in wild-type patients. Thus, it is worthwhile to explore the prognostic model for patients with positive driving genes.